首页 | 本学科首页   官方微博 | 高级检索  
     


Coccidioidomycosis of the male reproductive tract
Authors:Eric?S.?Halsey  author-information"  >  author-information__contact u-icon-before"  >  mailto:eric.halsey@wpafb.af.mil"   title="  eric.halsey@wpafb.af.mil"   itemprop="  email"   data-track="  click"   data-track-action="  Email author"   data-track-label="  "  >Email author,Mark?S.?Rasnake
Affiliation:(1) Department of Infectious Diseases, Wright-Patterson Air Force Base, OH, 45433, USA;(2) Department of Infectious Diseases, Wilford Hall Medical Center, Lackland Air Force Base, TX 78236, USA;(3) Infectious Disease Service, Brooke Army Medical Center, Fort Sam Houston, TX, USA;(4) Department of Infectious Diseases, Wright-Patterson Air Force Base, 74 MDOS/SGOM, 4881 Sugar Maple Drive, WPAFB OH 45433, USA
Abstract:Coccidioides immitis infection of the male reproductive tract is a rare entity that can evade diagnosis and pose a dilemma in management. Initially, patients are often evaluated for malignancy or other infections such as tuberculosis. In the past, surgery was the only management option for C. immitis infection of the male reproductive tract, but azole therapy now provides an adjunct or an alternative. We describe two patients who received azole therapy for C. immitis infection of the male reproductive tract. One received fluconazole for prostatic disease, while one received surgery followed by itraconazole for testicular disease. After 12 months of therapy, both remain asymptomatic and have decreased antibody titers against C. immitis.Disclaimer: The Views expressed herein are those of the authors do not reflect the official policy or position of the Department of the Air Force, Department of the Army, Department of Defence, or the U.S. Government.
Keywords:coccidioidomycosis  epididymis  male  prostate  testis
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号